Approval · Notice of Compliance 28728 · 2022
INCRELEX: Notice of Compliance 28728
Issued August 10, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28728
- Date
- August 10, 2022
- Company
- Ipsen Biopharmaceuticals Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INCRELEX | Not yet assigned | — |
Medicinal ingredients
- MECASERMIN 10 MG per ML